Dallas Formulations

Chandigarh, India Founded: 1998 • Age: 28 yrs
Manufactures pharmaceutical tablets, capsules, and injectables for health markets.

About Dallas Formulations

Dallas Formulations is a Healthcare company based in Chandigarh (India) founded in 1998. It manufactures pharmaceutical tablets, capsules, and injectables for health markets. It operates on a B2B and Ethical Marketing model. The company has 22 employees. Its Indian entity Dallas Formulations Private Limited reported revenue of β‚Ή10.53 Cr. Dallas Formulations offers products and services including Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups. Its focus areas include Pharmaceuticals, OTC Products, Tablets and Capsules and Drug Manufacturing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Dallas Formulations Pvt. Ltd. produces a range of pharmaceutical formulations including tablets, capsules, and injectables at facilities in Baddi and Vadodara. The company focuses on ethical marketing, contract manufacturing, and quality control to serve customers across India with safe and effective drugs. It emphasizes innovative products and compliance with industry standards for purity and efficacy.

Key Metrics
  • Annual Revenue
    ₹10.53 Cr

    FY 2025 · +47% YoY

  • Net Profit
    ₹17.3 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹85.6 Lakh

    FY 2025 · 8% margin

  • Employee Count
    22

Products & Services of Dallas Formulations

Dallas Formulations offers a comprehensive portfolio of products and services, including Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups.

Tablet Formulations
Drug Manufacturing

Formulates tablets for various health treatments.

Capsule Formulations
Drug Manufacturing

Produces capsules for medical applications.

Injectables Formulations
Drug Manufacturing

Develops injectable drugs for therapeutic use.

Derma Care Products
Drug Manufacturing

Offers formulations for skin and topical treatments.

Paediatric Syrups
Drug Manufacturing

Creates syrups for children's health needs.

Board of directors of Dallas Formulations Private Limited (Dallas Formulations)

Dallas Formulations Private Limited is the primary company behind Dallas Formulations. The board of Dallas Formulations Private Limited currently have 2 directors; the longest-serving is Rajesh Gupta, appointed in 2006. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Gupta
DIN 01639898
Director16 Jan 200620 yrs 10 moDallas Formulations Private Limited
Mukesh Kumar
DIN 09679383
Whole-time director21 Jul 20224 yrs 4 moDallas Formulations Private Limited

Financials of Dallas Formulations

Figures of Dallas Formulations Private Limited, the primary company behind Dallas Formulations, for FY 2025. Revenue was ₹10.53 Cr (+47% year on year). Net profit was ₹17.3 Lakh (2% margin). EBITDA was ₹85.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of +5% over three years and +2% over five years.

  • ₹10.53 CrRevenue · FY 2025 · +47% YoY
  • ₹17.3 LakhNet profit · 2% margin
  • ₹85.6 LakhEBITDA · 8% margin
  • ₹39.1 LakhPaid-up capital
  • 22Employees (provident fund records)
  • +5%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dallas Formulations Private Limited are on its company page.

Premium access

Detailed financial statements for Dallas Formulations

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Dallas Formulations

Dallas Formulations has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Dallas Formulations

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dallas Formulations

Dallas Formulations was founded in 1998.

Dallas Formulations is headquartered in Chandigarh, India.

Dallas Formulations has 22 employees.

The primary company behind Dallas Formulations, Dallas Formulations Private Limited, reported revenue of β‚Ή10.53 Cr for FY 2025, up 47% year on year.

Dallas Formulations Pvt. Ltd. produces a range of pharmaceutical formulations including tablets, capsules, and injectables at facilities in Baddi and Vadodara. The company focuses on ethical marketing, contract manufacturing, and quality control to serve customers across India with safe and effective drugs. It emphasizes innovative products and compliance with industry standards for purity and efficacy.

Dallas Formulations's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Dallas Formulations offers Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups.

Dallas Formulations operates through Dallas Formulations Private Limited.

The legal entities of Dallas Formulations currently have 2 directors, including Rajesh Gupta, Mukesh Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available